Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Jul 2, 2016
Filed with the SEC on Aug 5, 2016 and accepted by EDGAR at Aug 5, 2016, 12:04 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-07-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-04-03 to 2016-07-02 | $4.54bn | us-gaap:Revenues |
| Revenue | 6 months2016-01-01 to 2016-07-02 | $8.83bn | us-gaap:Revenues |
| Cost of revenue | 3 months2016-04-03 to 2016-07-02 | $2.04bn | us-gaap:CostOfGoodsSold |
| Cost of revenue | 6 months2016-01-01 to 2016-07-02 | $3.97bn | us-gaap:CostOfGoodsSold |
| Research and development | 3 months2016-04-03 to 2016-07-02 | $182.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2016-01-01 to 2016-07-02 | $358.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2016-04-03 to 2016-07-02 | $1.22bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2016-01-01 to 2016-07-02 | $2.44bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-04-03 to 2016-07-02 | $637.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2016-01-01 to 2016-07-02 | $1.16bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-04-03 to 2016-07-02 | $118.8m | us-gaap:InterestExpense |
| Interest expense | 6 months2016-01-01 to 2016-07-02 | $225.0m | us-gaap:InterestExpense |
| Income tax | 3 months2016-04-03 to 2016-07-02 | $4.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2016-01-01 to 2016-07-02 | $25.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-04-03 to 2016-07-02 | $516.6m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 6 months2016-01-01 to 2016-07-02 | $918.8m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months2016-04-03 to 2016-07-02 | $1.30 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2016-01-01 to 2016-07-02 | $2.31 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-04-03 to 2016-07-02 | $1.31 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2016-01-01 to 2016-07-02 | $2.33 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-04-03 to 2016-07-02 | 396,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2016-01-01 to 2016-07-02 | 397,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2016-01-01 to 2016-07-02 | $1.18bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2016-01-01 to 2016-07-02 | $229.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2016-01-01 to 2016-07-02 | $119.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2016-01-01 to 2016-07-02 | $1.00bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2016-07-02 | $663.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-07-02 | $6.33bn | us-gaap:AssetsCurrent |
| Total assets | At period end2016-07-02 | $42.25bn | us-gaap:Assets |
| Current liabilities | At period end2016-07-02 | $5.53bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | At period end2016-07-02 | $2.52bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2016-07-02 | $21.26bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2016-07-02 | 394,262,866 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000097745-16-000065. Last ingested by Listed: Nov 14, 2026, 12:05 ET. Listed shows no prices and gives no investment advice.